Autoimmune Polyglandular Syndrome Associated with Idiopathic Giant Cell Myocarditis

Abstract

The autoimmune polyglandular syndrome (APS) is characterized by a variable coexistence of several autoimmune diseases, affecting predominantly endocrine glands. In general two types of APS are distinguished. Type 1 APS is an autosomal recessive disorder often leading to insufficiency of the adrenal cortex, the parathyroid glands, and/or the gonads. This type of APS often affects the skin in form of chronic mucocutaneous candidiasis and ectodermal dystrophies (vitiligo, alopecia, keratopathy, dystrophy of dental enamel and nails). The second form of APS is a polygenic disease which usually involves the adrenal gland, the thyroid and the pancreatic beta-cells. In rare cases APS type 2 is associated with myasthenia gravis, autoimmune thrombocytopenic purpura, Sjogren's syndrome or rheumatoid arthritis. Here we describe a case of APS with the unusual combination of type 1 diabetes, secondary adrenocortical insufficiency, growth hormone deficiency, and primary hypothyroidism associated with lethal idiopathic giant cell myocarditis. The combination of APS and idiopathic giant cell myocarditis which is a rare, frequently fatal autoimmune disorder of myocardium affecting most commonly young individuals has not been reported so far.

Key words

Autoimmune polyglandular syndrome - idiopathic giant cell myocarditis

References

• 1 Abs R. Update on the diagnosis of GH deficiency in adults.  Eur J Endocrinol. 2003;  148 3-8
• 2 Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.  New Engl J Med. 1990;  322 1829-1836
• 3 Ariza A, Lopez M D, Mate J L, Curos A, Villagrasa M, Navas-Palacios J J. Giant cell myocarditis: monocytic immunophenotype of giant cells in a case associated with ulcerative colitis.  Hum Pathol. 1995;  26 121-123
• 4 Barkan A L, Kelch R P, Marshall J C. Isolated gonadotrope failure in the polyglandular autoimmune syndrome.  New Engl J Med. 1985;  312 1535-1540
• 5 Belvisi L, Bombelli F, Sironi L, Doldi N. Organ specific autoimmunity in patients with premature ovarian failure.  J Endocrinol Invest. 1993;  16 889-892
• 6 Benisch B M, Josephson M. Subacute (giant cell) thyroiditis and giant cell myocarditis in patient with carcinoma of lung.  Chest. 1973;  64 764-765
• 7 Betterle C, Greggio N A, Volpato M. Autoimmune polyglandular syndrome type 1.  J Clin Endocrinol Metab. 1998;  83 1049-1055
• 8 Bjorses P, Aaltonen J, Horelli-Kuitunen N, Yaspo M L, Peltonen L. Gene defect behind APECED: a new clue to autoimmunity.  Hum Mol Genet. 1998;  7 1547-1553
• 9 Brosnan P, Riley W J. Autoimmune polyglandular syndrome. Sperling MA Pediatric Endocrinology. Philadelphia; WB Sanders 1996: 509-522
• 10 Burke J S, Medline N M, Katz A. Giant cell myocarditis and myositis associated with thymoma and myasthenia gravis.  Arch Pathol. 1969;  88 359-366
• 11 Cihakova D, Trebusak K, Heino M, Fadeyev V, Tiulpakov A, Battelino T, Tar A, Halasz Z, Blumel P, Tawfik S, Krohn K, Lebl J, Peterson P. Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED.  Hum Mutat. 2001;  18 225-232
• 12 Costanzo-Nordin M R. Giant cell myocarditis: dramatic hemodynamic histologic improvement with immunosuppressive therapy.  Eur Heart J. 1987;  8 (Suppl) 271-274
• 13 Cooper Jr L T, Berry G J, Shabetai R. Giant-cell myocarditis - natural history and treatment.  New Engl J Med. 1997;  336 1860-1866
• 14 Cooper Jr L T, Berry G J, Rizeq M, Schroeder J S. Giant cell myocarditis.  J Heart Lung Transplant. 1995;  14 394-401
• 15 Davidoff R, Palacios I, Southern J, Falln J T, Newell J, Dec G W. Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes.  Circulation. 1991;  83 1110-1111
• 16 Davies M J, Pomerance A, Teare R D. Idiopathic giant cell myocarditis- a distinctive clinico-pathological entity.  Brit Heart J. 1975;  37 192-195
• 17 Desjardins V, Pelletier G, Leung T K, Waters D. Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis.  Can J Cardiol. 1992;  8 788-792
• 18 Eisenbarth G S, Gottlieb P A. Autoimmune polyendocrine syndromes.  New Engl J Med. 2004;  350 2068-2079
• 19 Forster G, Krummenauer F, Kuhn I, Beyer J, Kahaly G. Polyglandular autoimmune syndrome type II: epidemiology and forms of manifestation.  Dtsch Med Wochenschr. 1999;  124 1476-1481
• 20 Govindarajan R, Galpin O P. Coexistence of Addison's disease, ulcerative colitis, hypothyroidism and pernicious anemia.  J Clin Gastroenterol. 1992;  15 82-83
• 21 Heino M, Peterson P, Kudoh J, Shimuzu N, Antonarakis S E, Scott H S, Krohn K. APECED mutations in the autoimmune regulator (AIRE) gene.  Hum Mutat. 2001;  18 205-211
• 22 Heino M, Scott H S, Chen Q, Peterson P, Maebpaa U, Papasavvas M P, Mittaz L, Barras C, Rossier C, Chrousos G P, Stratakis C A, Nagamine K, Kudoh J, Shimizu N, Maclaren N, Antonarakis S E, Krohn K. Mutation analyses of North American APS-1 patients.  Hum Mutat. 1999;  13 69-74
• 23 Hoffmann D M, O'Sullivan A J, Baxter R C, Ho K K. Diagnosis of growth hormone deficiency in adults.  Lancet. 1994;  343 1064-1068
• 24 Hudson R. Giant cell myocarditis.  Arch Pathol. 1970;  88 359-366
• 25 Ishii T, Susuki Y, Ando Matsuo N N, Ogata T. Novel mutations of the autoimmune regulator gene in two siblings with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.  J Clin Endocrinol Metab. 2000;  85 2922-2926
• 26 Kennedy Jr L J, Mitchinson M J. Giant cell arteritis with myositis and myocarditis.  California Med. 1971;  115 84-87
• 27 Kilgallen C M, Jackson E, Bankoff M, Salomon R N, Surks H. A case of giant cell myocarditis and malignant thymoma: a postmortem diagnosis by needle biopsy.  Clin Cardiol. 1998;  21 48-51
• 28 Klein B R, Hedges 3rd T R. Orbital myositis and giant cell myocarditis.  Neurology. 1989;  399 988-990
• 29 Kloin J E. Pernicious anemia and giant cell myocarditis. New association.  Am J Med. 1985;  78 355-360
• 30 Ko G T, Szeto C C, Yeung V T, Chow C C, Chan H, Cockram C S. Autoimmune polyglandular syndrome and primary biliary cirrhosis.  Br J Clin Pract. 1996;  50 344-346
• 31 Kong M F, Jeffcoate W. Eighty-six cases of Addison's disease.  J Clin Endocrinol. 1994;  41 757-761
• 32 Kurokawa H, Numata Y, Nishioka T, Takao T, Hashimoto K. Secretion of anterior pituitary hormones in patients with insulin-dependent diabetes mellitus and polyglandular autoimmune syndrome.  Int Med (Tokyo, Japan). 1996;  35 686-692
• 33 Leib M L, Odel J G, Cooney M J. Orbital polymyositis and giant cell myocarditis.  Ophthalmology. 1994;  101 950-954
• 34 Leshin M. Polyglandular autoimmune syndromes.  Am J Medical Sciences. 1985;  290 77-88
• 35 Levy N T, Olson L J, Weyand C, Brack A, Tazelaar H D, Edwards W D, Hammill S C. Histologic and cytokine response to immunsuppression in giant cell myocarditis.  Ann Intern Med. 1998;  128 648-650
• 36 Maes M, Eisenbarth G S. The polyglandular autoimmune syndromes. Volpe R Contemporary Endocrinology: Autoimmune Endocrinopathies. Totowa; Humana Press Inc 1999: 349-364
• 37 McKeon J, Haagsma B, Bett J H, Boyle C M. Fatal giant cell myocarditis after colectomy for ulcerative colitis.  Am Heart J. 1986;  111 1208-1209
• 38 Muir A, Schatz D A, Maclaren N K. Polyglandular failure syndromes. De Groot LJ Endocrinology. Philadelphia; WB Sanders 1995: 3013-3024
• 39 Myhre A G, Bjorses P, Dalen A, Husebye E S. Three sisters with Addison's disease.  J Clin Endocrinol Metab. 1998;  83 4204-4206
• 40 Myhre A G, Halonen M, Eskelin P, Ekwal O, Hedstrand H, Rorsman F, Kampe O, Husebye E S. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.  Clin Endocrinol (Oxf). 2001;  54 211-217
• 41 Nagamine K, Peterson P, Scott H S, Kudoh J, Minoshima S, Heino M, Krohn K J, Lalioti M D, Mullis P E, Antonarakis S E, Kawasaki K, Asakawa S, Ito F, Shimizu N. Positional cloning of the APECED gene.  Nat Genet. 1997;  17 393-398
• 42 Nerup J. Addison's disease - clinical studies. A report of 108 cases.  Acta Endocrinol. 1974;  76 127
• 43 Neufeld M, Blizzard R M. Polyglandular autoimmune diseases. Pinchera A, Doniach D, Fenzi GF, Baschieri L Symposium on Autoimmune Aspects of Endocrine Disorders. New York; Academic Press 1980: 357-365
• 44 Neufeld M, Maclaren N K, Blizzard R M. Autoimmune polyglandular syndromes.  Pediatr Ann. 1980;  9 154-162
• 45 Neufeld M, Maclaren N K, Blizzard R M. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes.  Medicine (Baltimore). 1981;  60 355
• 46 Okada R, Wakafuji S. Myocarditis in autopsy.  Heart Vessels. 1985;  1 23-29
• 47 Ozawa Y, Shishiba Y. Recovery from lymphocytic hypophysitis associated with painless thyroiditis: clinical implications of circulating antipituitary antibodies.  Acta Endocrinol. 1995;  128 493-498
• 48 Pearce S H, Cheetham T, Imrie H, Vaidya B, Barnes N D, Bilous R W, Carr D, Meeran K, Shaw N J, Smith C S, Toft A D, Williams G, Kendall-Taylor P. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1.  Am J Hum Genet. 1998;  63 1675-1684
• 49 Perheentupa J. APS-1/APECED: the clinical disease and therapy.  Endocrinol Metab Clin North Am. 2002;  31 295-320
• 50 Redondo M J, Eisenbarth G S. Autoimmune polyendocrine syndrome type II. Eisenbarth GS Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity. Austin, TX; RG Landes Company 1999: 41-46
• 51 Roberts W, Wibin E. Idiopathic panaortitis, supra-aortic arteritis, granulomatous myocarditis and pericarditis. A case of pulseless disease and possibly left ventricular aneurysm in the African.  Am J Med. 1966;  41 453-461
• 52 Roberts W C, Kehoe J A, Carpenter D F, Golden A. Cardiac valvular lesions in rheumatoid arthritis.  Arch Intern Med. 1968;  122 141-146
• 53 Rosatelli M C, Meloni A, Meloni A, Devoto M, Cao A, Scott H S, Peterson P, Heino M, Krohn K J, Nagamine K, Kudoh J, Shimizu N, Antonarakis S E. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients.  Hum Genet. 1998;  103 428-434
• 54 Ruegg S, Stahl M, Buhlmann M, Dupont A, Lyrer P A, Humbel R L, Steck A J. Cerebellar degeneration and polyglandular autoimmune syndrome with anti-glutamic acid decarboxylase antibodies.  J Neurol. 2002;  249 348-350
• 55 Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz J J, Tolosa E, Graus F. Autoantibodies to glutamic aciddecarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.  Neurology. 1997;  49 1026-1030
• 56 Saugier-Veber P, Drouot N, Wolf L M, Kuhn J M, Frebourg T, Lefebvre H. Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.  Europ J Endocrinol. 2001;  144 347-351
• 57 Scott H S, Heino M, Peterson P, Mittaz L, Lalioti M D, Betterle C, Cohen A, Seri M, Lerone M, Romeo G, Collin P, Salo M, Metcalfe R, Weetman A, Papasavvas M P, Rossier C, Nagamine K, Kudoh J, Shimizu N, Krohn K J, Antonarakis S E. Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins.  Mol Endocrinol. 1998;  12 1112-1119
• 58 Soderbergh A, Rorsman F, Halonen M, Ekwall O, Bjorses P, Kampe O, Husebye E S. Autoantibodies against aromatic L-amino acid decarboxylaseidentifies a subgroup of patients with Addison's disease.  J Clin Endocrinol Metab. 2000;  85 460-463
• 59 Solimena M, Piccolo G, Martino G. Autoantibodies directed against gabaergic nerve terminals in a patient with idiopathic late-onset cerebellar ataxia and type 1 B diabetes mellitus.  Clin Neuropathol. 1998;  7 211
• 60 The Finnish-German APECED Consortium . Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains.  Nat Genet. 1997;  17 399-403
• 61 Theaker J M, Gatter K C, Brown D C, Heryet A, Davies M J. An investigation into the nature of giant cells in cardiac and skeletal muscle.  Hum Pathol. 1988;  19 974-979
• 62 Thorner M O, Bengtsson B A, Ho K KY, Albertsson-Wikland K M, Christiansen J S, Faglia G. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency.  J Clin Endocrinol Metab. 1998;  83 379-381
• 63 Trence D L, Morley J E, Handwerger B S. Polyglandular autoimmune syndromes.  Am J Med. 1984;  77 107
• 64 Vogel A, Strassburg C P, Obermayer-Straub P, Brabant G, Manns M P. Autoimmun-polyglanduläre Syndrome.  Dtsch Ärztebl. 2002;  99 1428-1434
• 65 Wang C Y, Davoodi-Semiromi A, Huang W, Connor E, Shi J D, She J X. Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS 1).  Hum Gen. 1998;  103 681-685
• 66 Ward L, Paquette J, Seidman E, Huot C, Alvarez F, Crock P, Delvin E, Kampe O, Deal C. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy.  J Clin Endocrinol Metabolism. 1999;  84 844
• 67 Watson P J, Lewis R A. Schmidt's syndrome associated with sarcoidosis.  Postgrad Med J. 1996;  72 435-436
• 68 Whitehead R. Isolated myocarditis.  Brit Heart J. 1965;  27 220-230
• 69 Zlotogora J, Shapiro M S. Polyglandular autoimmune syndrome type I among Iranian Jews.  J Med Genet. 1992;  20 824-826